Including market leading Arrow™ CVCs and Arterial Catheters Including market leading Arrow™ CVCs and Arterial Catheters
Other News
Johnson & Johnson Statement on VARIPULSE™ U.S. External Evaluation
New Brunswick, NJ, January 8, 2025 – At Johnson & Johnson MedTech, the health and safety of our patients is our top priority. On January 5, out of an abundance of caution, Johnson & Johnson MedTech temporarily paused the U.S. External Evaluation and all U.S. VARIPULSE™ cases while we investigate the root cause of four […]
NorthStar Medical Radioisotopes and YAP Therapeutics Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products
orthStar to support the development of YAP Therapeutics’ innovative radiolabeled products This collaboration merges the expertise and resources from both companies, including NorthStar’s state-of-the-art facilities The agreement guarantees that YAP Therapeutics will receive clinical trial-ready doses of its novel products in development January 08, 2025 08:01 AM Eastern Standard Time […]
CARMAT Delivers a Solid FY 2024 with 42 Implants of Its Aeson® Artificial Heart and Anticipates Continued Strong Momentum in 2025
Over 90 patients have received the Aeson® artificial heart since the first implant in 2013, including 42 in 2024. 2024 Sales of €7 million (a 2.5-fold increase vs 2023). Cash burn reduced by over 20% vs 2023. 50 hospitals trained in Aeson® implants internationally1. Successful first “Aeson® User Meeting” and […]
Fauna Bio Announces First Candidate Nomination of Faun1083 for the Treatment of Heart Failure
EMERYVILLE, Calif.–(BUSINESS WIRE)–Fauna Bio, a biotechnology company improving human health by leveraging animal genomics, today announced Faun1083 as its first development candidate. Discovered through Fauna Bio’s proprietary Convergence™ drug discovery platform, Faun1083 is a potential first-in-class therapeutic targeting heart failure with preserved ejection fraction (HFpEF), a disease with currently limited […]
Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer
BURLINGTON, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company discovering and developing new therapeutic approaches for the treatment of cardiovascular diseases, today announced that Charlotte (Charlie) Newman has joined the company as Chief Business Officer. A biopharmaceutical industry executive with over 25 years of industry experience, Ms. Newman most recently […]
Relief Cardiovascular Announces $12M Series A Financing to Advance First-in-Human Study of the Relief System
IRVINE, Calif., Jan. 8, 2025 /PRNewswire/ — Relief Cardiovascular, an inQB8 Medical Technologies portfolio company pioneering innovative solutions for the management of heart failure, today announced the closing of a $12M Series A financing. The funding round was co-led by Broadview…
Arch Biopartners Announces Ontario Research Ethics Board Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University Health Network Research Ethics Board, through the Clinical Trials Ontario Streamlined Research Ethics Review System, has granted provincial ethics approval for the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.
Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform, furthering company’s strategy to address coronary and peripheral disease MARLBOROUGH, Mass., Jan. 8, 2025 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today…
Investor Insights: Mike Carusi Lightstone Ventures – Investment size, typical investment
Recent
FLEX Vascular Announces 12-Month Real-World Outcomes Demonstrating Strong Safety, Durability, and Reduced Reinterventions with FLEX™ Vessel Prep System
NorthStar Mapping System Now Commercially Available in the United States
HOPPR Expands Medical Imaging AI Portfolio with Chest Radiography Narrative Model
Popular
- No commented posts yet